A drug used to treat manic-depressive illness has been recalled by Health Canada.
Carbolith 150 milligram capsules, distributed in Canada by Valeant Canada Limited, has been recalled after company testing found the medication may not deliver adequate amounts of the drug to ensure effective treatment. As a precaution, Health Canada is advising people taking the drug to continue on their medication but consult their doctor as soon as possible.
Potential adverse reactions to the product could include a worsening of manic-depressive illness, a serious psychiatric condition.
A worsening of the condition could cause symptoms associated with mania, which may include motor hyperactivity, delusions of grandeur, poor judgment and aggressiveness.
Additionally, there is a potential risk that a toxic effect might occur in patients who are used to the lower than expected release of drug when exposed to the full drug dosage.
Mild toxicity could result in tremors of the hands, thirst and more frequent urination, drowsiness, ringing in the ears and blurred vision. More severe toxicity could result in confusion, muscle twitching, vomiting, diarrhea, seizures, coma and death.